Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer.

Nat Med · 2018 · PMC6130800 · PMID 30038216

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This overlap is highly significant specifically for enhancers but not for other annotations ( Fig. 1F-G ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.